Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas

被引:0
作者
Zhou, Shuigen [1 ]
Wang, Longxin [1 ]
Li, Guimei [2 ]
Zhang, Zhengyu [1 ]
Wang, Jiandong [3 ]
机构
[1] Nanjing Univ, Dept Urol, Jinling Hosp, Sch Med, Nanjing 210002, Jiangsu, Peoples R China
[2] 81 Hosp, Dept Pathol, Nanjing 210002, Jiangsu, Peoples R China
[3] Nanjing Univ, Dept Pathol, Jinling Hosp, Sch Med, Nanjing 210002, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
EphB1; renal cell carcinoma; down-regulation; VHL; EPHA2; PROLIFERATION; METASTASIS; STAGE; GENE; MET; PROGNOSIS; INVASION; TARGET;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Receptors tyrosine kinase of Eph superfamily plays an important role in human cancers. We previously found that EphB1 subtype is down-regulated in gastric cancer, colorectal cancer and ovary serous carcinoma. Fore the more, the decreased expression of EphB1 is related to invasion and metastasis in cancers. Although EphB1 has been revealed as an important receptor in cancers, our understanding of its roles in renal cell carcinoma (RCC) is limited. In the present study, using specific anit-EphB1 polyclonal antibody and immunohistochemistry, we evaluated EphB1 protein expression levels in RCC specimens surgically resected from 82 patients (including 62 conventional clear-cell RCC, 10 papillary, and 10 chromophobic RCC cases). We found EphB1 protein is positively expressed in the epithelium of renal tubules. Decreased expression of EphB1 was found in all RCC carcinomas compared with expression in the normal epithelium of renal tubules. EphB1 protein moderately expressed in chromophobic RCC, weakly expressed in clear-cell RCC and negatively expressed in papillary RCC. Our results indicate that EphB1 may be involved in carcinogenesis of RCC, the molecular mechanisms of down-regulation of EphB1 including genetic and epigenetic alterations and the dedicated roles of EphB1 in occurrence and progress of RCC need to be explicated in next step.
引用
收藏
页码:4254 / 4260
页数:7
相关论文
共 35 条
[1]   MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array [J].
Albiges, Laurence ;
Guegan, Justine ;
Le Formal, Audrey ;
Verkarre, Virginie ;
Rioux-Leclercq, Nathalie ;
Sibony, Mathilde ;
Bernhard, Jean-Christophe ;
Camparo, Philippe ;
Merabet, Zahira ;
Molinie, Vincent ;
Allory, Yves ;
Orear, Cedric ;
Couve, Sophie ;
Gad, Sophie ;
Patard, Jean-Jacques ;
Escudier, Bernard .
CLINICAL CANCER RESEARCH, 2014, 20 (13) :3411-3421
[2]   ERK5/BMK1 Is a Novel Target of the Tumor Suppressor VHL: Implication in Clear Cell Renal Carcinoma [J].
Arias-Gonzalez, Laura ;
Moreno-Gimeno, Inmaculada ;
Rubio del Campo, Antonio ;
Serrano-Oviedo, Leticia ;
Llanos Valero, Maria ;
Esparis-Ogando, Azucena ;
Angel de la Cruz-Morcillo, Miguel ;
Melgar-Rojas, Pedro ;
Garcia-Cano, Jesus ;
Jose Cimas, Francisco ;
Ruiz Hidalgo, Maria Jose ;
Prado, Alfonso ;
Luis Callejas-Valera, Juan ;
Hyun Nam-Cha, Syong ;
Miguel Gimenez-Bachs, Jose ;
Salinas-Sanchez, Antonio S. ;
Pandiella, Atanasio ;
del Peso, Luis ;
Sanchez-Prieto, Ricardo .
NEOPLASIA, 2013, 15 (06) :649-+
[3]   Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC [J].
Arnato, Katherine R. ;
Wang, Shan ;
Hastings, Andrew K. ;
Youngblood, Victoria M. ;
Santapuram, Pranav R. ;
Chen, Haiying ;
Cates, Justin M. ;
Colvin, Daniel C. ;
Ye, Fei ;
Brantley-Sieders, Dana M. ;
Cook, Rebecca S. ;
Tan, Li ;
Gray, Nathanael S. ;
Chen, Jin .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (05) :2037-2049
[4]  
Brauch H, 2000, CANCER RES, V60, P1942
[5]   Renal cell carcinoma [J].
Cairns, Paul .
CANCER BIOMARKERS, 2011, 9 (1-6) :461-473
[6]  
Chen Jin, 2008, Cancer Res, V68, P10031, DOI 10.1158/0008-5472.CAN-08-3010
[7]   miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression [J].
Chen, Xuanyu ;
Wang, Xuegang ;
Ruan, Anming ;
Han, Weiwei ;
Zhao, Yan ;
Lu, Xing ;
Xiao, Pei ;
Shi, Hangchuan ;
Wang, Rong ;
Chen, Li ;
Chen, Shaoyong ;
Du, Quansheng ;
Yang, Hongmei ;
Zhang, Xiaoping .
CLINICAL CANCER RESEARCH, 2014, 20 (10) :2617-2630
[8]   The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma [J].
Choueiri, Toni K. ;
Fay, Andre P. ;
Gagnon, Robert ;
Lin, Ying ;
Bahamon, Brittany ;
Brown, Victoria ;
Rosenberg, Jonathan E. ;
Hutson, Thomas E. ;
Baker-Neblett, Katherine L. ;
Carpenter, Christopher ;
Liu, Yuan ;
Pandite, Lini ;
Signoretti, Sabina .
CLINICAL CANCER RESEARCH, 2013, 19 (18) :5218-5226
[9]   Role of transforming growth factor-α in von Hippel-Lindau (VHL)-/- clear cell renal carcinoma cell proliferation:: A possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis [J].
de Paulsen, N ;
Brychzy, A ;
Fournier, MC ;
Klausner, RD ;
Gnarra, JR ;
Pause, A ;
Lee, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1387-1392
[10]   The role of Eph receptors and ephrin ligands in colorectal cancer [J].
Herath, Nirmitha I. ;
Boyd, Andrew W. .
INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (09) :2003-2011